Human iPSC derived disease model of MERTK-associated retinitis pigmentosa

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lukovic, Dunja ^a   Castro, Ana Artero ^a   Delgado, Ana Belen Garcia ^a   Bernal, María De Los Angeles Martín ^a   Pelaez, Noelia Luna ^a   Lloret, Andrea Díez ^a   Espejo, Rocío Perez ^a   Kamenarova, Kunka ^a   Sánchez, Laura Fernández ^c   Cuenca, Nicolás ^c   Cortón, Marta ^d,e   Fernandez, Almudena Avila ^d,e   Sorkio, Anni ^f   Skottman, Heli ^f   Ayuso, Carmen ^d,e   Erceg, Slaven ^a,b   Bhattacharya, Shomi S ^a  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF ALICANTE   (Spain)

^d UAM)   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MERTK PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL; BIOLOGICAL MODEL; CASE CONTROL STUDY; CELL DIFFERENTIATION; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; PATHOLOGY; PHYSIOLOGY; RETINITIS PIGMENTOSA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RETINITIS PIGMENTOSA;

EID: 84939144654     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12910     Document Type: Article

References (39)

1. Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795-1809, doi: 10.1016/S0140-6736(06)69740-7 (2006).
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi: 10.1016/j.cell.2007.11.019 (2007).
3. Lamba, D. A. et al. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PloS one 5, e8763, doi: 10.1371/journal.pone.0008763 (2010).
4. Ikeda, H. et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 102, 11331-11336, doi: 10.1073/pnas.0500010102 (2005).
5. Osakada, F., Ikeda, H., Sasai, Y. & Takahashi, M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nature protocols 4, 811-824, doi: 10.1038/nprot.2009.51 (2009).
6. Vaajasaari, H. et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Molecular vision 17, 558-575 (2011).
7. Carr, A. J. et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Molecular vision 15, 283-295 (2009).
8. Li, Y. et al. Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Molecular therapy : the journal of the American Society of Gene Therapy 22, 1688-1697, doi: 10.1038/mt.2014.100 (2014).
9. Singh, R. et al. iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Human molecular genetics 22, 593-607, doi: 10.1093/hmg/dds469 (2013).
10. Jin, Z. B. et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PloS one 6, e17084, doi: 10.1371/journal.pone.0017084 (2011).
11. Carr, A. J. et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PloS one 4, e8152, doi: 10.1371/journal.pone.0008152 (2009).
12. Li, Y. et al. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 18, 1312-1319, doi: 10.2119/molmed.2012.00242 (2012).
13. Kamao, H. et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem cell reports 2, 205-218, doi: 10.1016/j.stemcr.2013.12.007 (2014).
14. Reardon, S. & Cyranoski, D. Japan stem-cell trial stirs envy. Nature 513, 287-288, doi: 10.1038/513287a (2014).
15. Linger, R. M., Keating, A. K., Earp, H. S. & Graham, D. K. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Advances in cancer research 100, 35-83, doi: 10.1016/S0065-230X(08)00002-X (2008).
16. D'Cruz, P. M. et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Human molecular genetics 9, 645-651 (2000).
17. Nandrot, E. et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiology of disease 7, 586-599, doi: 10.1006/nbdi.2000.0328 (2000).
18. Gal, A. et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nature genetics 26, 270-271, doi: 10.1038/81555 (2000).
19. Duncan, J. L. et al. An RCS-like retinal dystrophy phenotype in mer knockout mice. Investigative ophthalmology & visual science 44, 826-838 (2003).
20. Charbel Issa, P. et al. Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene. The British journal of ophthalmology 93, 920-925, doi: 10.1136/bjo.2008.147397 (2009).
21. Finnemann, S. C., Bonilha, V. L., Marmorstein, A. D. & Rodriguez-Boulan, E. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proceedings of the National Academy of Sciences of the United States of America 94, 12932-12937 (1997).
22. Finnemann, S. C. Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors. The EMBO journal 22, 4143-4154, doi: 10.1093/emboj/cdg416 (2003).
23. Burstyn-Cohen, T. et al. Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis. Neuron 76, 1123-1132, doi: 10.1016/j.neuron.2012.10.015 (2012).
24. Caberoy, N. B. Synergistic interaction of tubby and tubby-like protein 1 (Tulp1). Advances in experimental medicine and biology 801, 503-509, doi: 10.1007/978-1-4614-3209-8-64 (2014).
25. Strick, D. J., Feng, W. & Vollrath, D. Mertk drives myosin II redistribution during retinal pigment epithelial phagocytosis. Investigative ophthalmology & visual science 50, 2427-2435, doi: 10.1167/iovs.08-3058 (2009).
26. Khajavi, M., Inoue, K. & Lupski, J. R. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. European journal of human genetics : EJHG 14, 1074-1081, doi: 10.1038/sj.ejhg.5201649 (2006).
27. Subrizi, A. et al. Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials 33, 8047-8054, doi: 10.1016/j.biomaterials.2012.07.033 (2012).
28. Chen, J., Carey, K. & Godowski, P. J. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14, 2033-2039, doi: 10.1038/sj.onc.1201039 (1997).
29. Williams, D. S. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision research 48, 433-441, doi: 10.1016/j.visres.2007.08.015 (2008).
30. van den Hurk, J. A. et al. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Human molecular genetics 6, 851-858 (1997).
31. Brea-Fernandez, A. J. et al. Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa. The British journal of ophthalmology 92, 1419-1423, doi: 10.1136/bjo.2008.139204 (2008).
32. Ksantini, M., Lafont, E., Bocquet, B., Meunier, I. & Hamel, C. P. Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa. European journal of ophthalmology 22, 647-653, doi: 10.5301/ejo.5000096 (2012).
33. Mackay, D. S. et al. Novel mutations in MERTK associated with childhood onset rod-cone dystrophy. Molecular vision 16, 369-377 (2010).
34. McHenry, C. L. et al. MERTK arginine-844-cysteine in a patient with severe rod-cone dystrophy: loss of mutant protein function in transfected cells. Investigative ophthalmology & visual science 45, 1456-1463 (2004).
35. Tschernutter, M. et al. Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. The British journal of ophthalmology 90, 718-723, doi: 10.1136/bjo.2005.084897 (2006).
36. Gundersen, D., Orlowski, J. & Rodriguez-Boulan, E. Apical polarity of Na,K-ATPase in retinal pigment epithelium is linked to a reversal of the ankyrin-fodrin submembrane cytoskeleton. The Journal of cell biology 112, 863-872 (1991).
37. Liang, G. & Zhang, Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell stem cell 13, 149-159, doi: 10.1016/j.stem.2013.07.001 (2013).
38. Sgodda, M. & Cantz, T. Small but significant: inter-and intrapatient variations in iPS cell-based disease modeling. Molecular therapy : the journal of the American Society of Gene Therapy 21, 5-7, doi: 10.1038/mt.2012.273 (2013).
39. Molday, R. S., Hicks, D. & Molday, L. Peripherin. A rim-specific membrane protein of rod outer segment discs. Investigative ophthalmology & visual science 28, 50-61 (1987).